Tablet-making makeover a U.K. effort

Continuous processing, rather than batch, may be the future of tablet-making. A U.K. group is targeting efficiency gains in manufacturing to effect cost savings big enough to help U.K. companies compete against lower cost economies.

"The traditional tablet manufacturing process has evolved into one that is easy to regulate but very manual and therefore expensive," says Adrian Howson, pharmaceutical process head at technology management and product development consultancy Sagentia, part of an industry/academia consortium. The efficiency gains are aimed at improving manufacturing precision, productivity and mass yield.

The consortium work is funded by the government-supported Technology Strategy Board, a U.K. body that supports technological innovation in manufacturing. Consortium members include GlaxoSmithKline, GEA Pharma Systems Ltd., Siemens Industrial Automation, the University of Warwick, and Newcastle University.

- read the item


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.